XML 81 R66.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Lines of Credit and Long Term Debt - Long Term Debt - Additional Information (Details) (USD $) | 3 Months Ended | 24 Months Ended |  |
--- | --- | --- | --- | ---
Mar. 31, 2015 | Mar. 31, 2015 | Dec. 31, 2014 | Mar. 15, 2013
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | $ 9,726,000 us-gaap_LongTermDebt | $ 9,726,000 us-gaap_LongTermDebt | $ 10,369,000 us-gaap_LongTermDebt |
Notes payable to banks | Trans Ova Genetics, LC | American State Bank |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 5,866,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_AmericanStateBankMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableToBanksMember | 5,866,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_AmericanStateBankMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableToBanksMember |  |
Periodic payment amount | 39,000 us-gaap_DebtInstrumentPeriodicPayment / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_AmericanStateBankMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableToBanksMember |  |  |
Interest rate | 3.95%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_AmericanStateBankMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableToBanksMember | 3.95%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_AmericanStateBankMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableToBanksMember |  |
Notes payable |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 7,360,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember | 7,360,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember | 7,653,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
Notes payable | Trans Ova Genetics, LC | Iowa Economic Development Authority |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 916,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_IowaEconomicDevelopmentAuthorityMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember | 916,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_IowaEconomicDevelopmentAuthorityMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |  |
Periodic principal payment amount | 183,000 us-gaap_DebtInstrumentPeriodicPaymentPrincipal / dei_LegalEntityAxis = xon_TransOvaGeneticsLcMember / us-gaap_LineOfCreditFacilityAxis = xon_IowaEconomicDevelopmentAuthorityMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |  |  |
Notes payable | Exemplar Genetics, LLC |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 578,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember | 578,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |  |
Notes payable | Exemplar Genetics, LLC | Minimum |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Periodic payment amount | 1,000 us-gaap_DebtInstrumentPeriodicPayment / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MinimumMember |  |  |
Interest rate | 0.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MinimumMember | 0.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MinimumMember |  |
Notes payable | Exemplar Genetics, LLC | Maximum |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Periodic payment amount | 4,000 us-gaap_DebtInstrumentPeriodicPayment / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MaximumMember |  |  |
Interest rate | 3.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MaximumMember | 3.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / dei_LegalEntityAxis = xon_ExemplarGeneticsLLCMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember / us-gaap_RangeAxis = us-gaap_MaximumMember |  |
Royalty-based financing |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 1,868,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember | 1,868,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember | 1,926,000 us-gaap_LongTermDebt / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember |
Royalty-based financing | AquaBounty Technologies, Inc. | Atlantic Canada Opportunities Agency |  |  |  |
Debt Instrument [Line Items] |  |  |  |
Outstanding principal balance | 1,868,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember | 1,868,000 us-gaap_LongTermDebt / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember |  |
Amount available under financial grant for research and development | 2,271,000 xon_AmountAvailableUnderFinancialGrantForResearchAndDevelopment / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember | 2,271,000 xon_AmountAvailableUnderFinancialGrantForResearchAndDevelopment / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember |  |
Period to claim funding from government award | 5 years |  |  |
Royalty rate to be paid | 10.00%xon_RateOfRoyaltyAgreedToBePaid / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember |  |  |
Amount claimed under financial grant |  |  |  | 1,952,000 xon_AmountClaimedUnderFinancialGrant / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember
Long term debt |  |  |  | 1,107,000 us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember
Accreted difference between face value of amount drawn and acquisition date fair value |  |  |  | (845,000)xon_AccretedDifferenceBetweenFaceValueOfAmountDrawnAndAcquisitionDateFairValue / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember
Proceeds from issuance of debt |  | $ 811,000 us-gaap_ProceedsFromIssuanceOfDebt / dei_LegalEntityAxis = xon_AquaBountyMember / us-gaap_LineOfCreditFacilityAxis = xon_AtlanticCanadaOpportunitiesAgencyMember / us-gaap_LongtermDebtTypeAxis = xon_RoyaltybasedFinancingMember |  |

X
- Definition Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_DebtInstrumentLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the required periodic payments including both interest and principal payments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823 + Details
Name: | us-gaap_DebtInstrumentPeriodicPayment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the required periodic payments applied to principal. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 + Details
Name: | us-gaap_DebtInstrumentPeriodicPaymentPrincipal
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 7 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.16) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 16 -Article 9 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20, 22 -Article 5 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.16) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 + Details
Name: | us-gaap_LongTermDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt. + References No definition available. + Details
Name: | us-gaap_ProceedsFromIssuanceOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Accreted Difference Between Face Value Of Amount Drawn And Acquisition Date Fair Value + References No definition available. + Details
Name: | xon_AccretedDifferenceBetweenFaceValueOfAmountDrawnAndAcquisitionDateFairValue
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount available under research and development grant + References No definition available. + Details
Name: | xon_AmountAvailableUnderFinancialGrantForResearchAndDevelopment
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount claimed under research and development grant to date + References No definition available. + Details
Name: | xon_AmountClaimedUnderFinancialGrant
Namespace Prefix: | xon_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Length of period during which amounts can be claimed under research and development grant + References No definition available. + Details
Name: | xon_GovernmentAwardClaimPeriod
Namespace Prefix: | xon_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of royalty on products commercialized under research and development grant + References No definition available. + Details
Name: | xon_RateOfRoyaltyAgreedToBePaid
Namespace Prefix: | xon_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=xon_RoyaltybasedFinancingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |